Gabapentin for Pain Management During Dilation and Evacuation

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

May 26, 2017

Primary Completion Date

May 9, 2019

Study Completion Date

May 20, 2020

Conditions
Pain
Interventions
DRUG

Gabapentin

Gabapentin (Neurontin®) is FDA-approved for the treatment of post-herpetic neuralgia and seizure disorder. Off-label uses include chronic refractory cough, neuropathy, hot flashes, restless leg syndrome, social anxiety disorder, and post-operative pain

DRUG

Placebo

Methylcellulose placebo capsule

Trial Locations (2)

20002

Planned Parenthood, Washington D.C.

20010

MedStar Washington Hospital Center, Washington D.C.

All Listed Sponsors
collaborator

Society of Family Planning Research Fund

UNKNOWN

lead

Medstar Health Research Institute

OTHER